Literature DB >> 19389372

The role of Wnt5a in prostate gland development.

Liwei Huang1, Yongbing Pu, Wen Yang Hu, Lynn Birch, Douglas Luccio-Camelo, Terry Yamaguchi, Gail S Prins.   

Abstract

The Wnt genes encode a large family of secreted glycoproteins that play important roles in controlling tissue patterning, cell fate and proliferation during development. Currently, little is known regarding the role(s) of Wnt genes during prostate gland development. The present study examines the role of the noncanonical Wnt5a during prostate gland development in rat and murine models. In the rat prostate, Wnt5a mRNA is expressed by distal mesenchyme during the budding stage and localizes to periductal mesenchymal cells with an increasing proximal-to-distal gradient during branching morphogenesis. Wnt5a protein is secreted and localizes to periductal stroma, extracellular matrix and epithelial cells in the distal ducts. While Wnt5a expression is high during active morphogenesis in all prostate lobes, ventral prostate (VP) expression declines rapidly following morphogenesis while dorsal (DP) and lateral lobe (LP) expression remains high into adulthood. Steroids modulate prostatic Wnt5a expression during early development with testosterone suppressing Wnt5a and neonatal estrogen increasing expression. In vivo and ex vivo analyses of developing mouse and rat prostates were used to assess the functional roles of Wnt5a. Wnt5a(-/-) murine prostates rescued by organ culture exhibit disturbances in bud position and directed outgrowth leading to large bulbous sacs in place of elongating ducts. In contrast, epithelial cell proliferation, ductal elongation and branchpoint formation are suppressed in newborn rat prostates cultured with exogenous Wnt5a protein. While renal grafts of Wnt5a(-/-) murine prostates revealed that Wnt5a is not essential for cyto- and functional differentiation, a role in luminal cell polarity and lumenization of the ducts was indicated. Wnt5a suppresses prostatic Shh expression while Shh stimulates Wnt5a expression in a lobe-specific manner during early development indicating that Wnt5a participates in cross-talk with other members of the gene regulatory network that control prostate development. Although Wnt5a does not influence prostatic expression of other Wnt morphogens, it suppresses Wif-1 expression and can thus indirectly modulate Wnt signaling. In summary, the present finds demonstrate that Wnt5a is essential for normal prostate development where it regulates bud outgrowth, ductal elongation, branching, cell polarity and lumenization. These findings contribute to the growing body of knowledge on regulatory mechanisms involved in prostate gland development which are key to understanding abnormal growth processes associated with aging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389372      PMCID: PMC2828764          DOI: 10.1016/j.ydbio.2009.01.003

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  59 in total

Review 1.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.

Authors:  Michael T Veeman; Jeffrey D Axelrod; Randall T Moon
Journal:  Dev Cell       Date:  2003-09       Impact factor: 12.270

Review 2.  Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development.

Authors:  Liwei Huang; Yongbing Pu; Shumyle Alam; Lynn Birch; Gail S Prins
Journal:  J Androl       Date:  2004 May-Jun

Review 3.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

4.  Identification of known and novel genes whose expression is regulated by endogenous retinoic acid during early embryonic development of the mouse.

Authors:  Miao-Hsueh Chen; Laurent Antoni; Rachid Tazi-Ahnini; Mike Cork; Simon J Ward; Claes O Båvik
Journal:  Mech Dev       Date:  2002-06       Impact factor: 1.882

5.  beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis.

Authors:  Michael L Mucenski; Susan E Wert; Jennifer M Nation; David E Loudy; Joerg Huelsken; Walter Birchmeier; Edward E Morrisey; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2003-07-28       Impact factor: 5.157

Review 6.  Beta-catenin signaling in prostate cancer: an early perspective.

Authors:  D R Chesire; W B Isaacs
Journal:  Endocr Relat Cancer       Date:  2003-12       Impact factor: 5.678

7.  Retinoic acid receptors and retinoids are up-regulated in the developing and adult rat prostate by neonatal estrogen exposure.

Authors:  Gail S Prins; William Y Chang; Yan Wang; Richard B van Breemen
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

8.  A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo.

Authors:  T P Yamaguchi; A Bradley; A P McMahon; S Jones
Journal:  Development       Date:  1999-03       Impact factor: 6.868

9.  FGF-10 plays an essential role in the growth of the fetal prostate.

Authors:  Annemarie A Donjacour; Axel A Thomson; Gerald R Cunha
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

10.  Wnt7b regulates mesenchymal proliferation and vascular development in the lung.

Authors:  Weiguo Shu; Yue Qin Jiang; Min Min Lu; Edward E Morrisey
Journal:  Development       Date:  2002-10       Impact factor: 6.868

View more
  47 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.

Authors:  Xinyu Wu; Kun Xu; Lixia Zhang; Yan Deng; Peng Lee; Ellen Shapiro; Marie Monaco; Helen P Makarenkova; Juan Li; Herbert Lepor; Irina Grishina
Journal:  Dev Biol       Date:  2011-05-20       Impact factor: 3.582

Review 3.  Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.

Authors:  Vatsal Mehta; Chad M Vezina
Journal:  Differentiation       Date:  2011 Nov-Dec       Impact factor: 3.880

Review 4.  Wnt5a as an effector of TGFβ in mammary development and cancer.

Authors:  Rosa Serra; Stephanie L Easter; Wen Jiang; Sarah E Baxley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-18       Impact factor: 2.673

5.  The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia.

Authors:  Shinichi Miyagawa; Daisuke Matsumaru; Aki Murashima; Akiko Omori; Yoshihiko Satoh; Ryuma Haraguchi; Jun Motoyama; Taisen Iguchi; Naomi Nakagata; Chi-Chung Hui; Gen Yamada
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

Review 6.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

7.  RET-mediated glial cell line-derived neurotrophic factor signaling inhibits mouse prostate development.

Authors:  Hyun-Jung Park; Eric C Bolton
Journal:  Development       Date:  2017-05-15       Impact factor: 6.868

8.  A possible zebrafish model of polycystic kidney disease: knockdown of wnt5a causes cysts in zebrafish kidneys.

Authors:  Liwei Huang; An Xiao; Andrea Wecker; Daniel A McBride; Soo Young Choi; Weibin Zhou; Joshua H Lipschutz
Journal:  J Vis Exp       Date:  2014-12-02       Impact factor: 1.355

9.  Androgenic regulation of ventral epithelial bud number and pattern in mouse urogenital sinus.

Authors:  Sarah H Allgeier; Tien-Min Lin; Robert W Moore; Chad M Vezina; Lisa L Abler; Richard E Peterson
Journal:  Dev Dyn       Date:  2010-02       Impact factor: 3.780

10.  Wnt signaling though beta-catenin is required for prostate lineage specification.

Authors:  Brian W Simons; Paula J Hurley; Zhenhua Huang; Ashley E Ross; Rebecca Miller; Luigi Marchionni; David M Berman; Edward M Schaeffer
Journal:  Dev Biol       Date:  2012-08-30       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.